Researchers at The University of Texas MD Anderson Cancer Center have identified a biomarker living next door to the KLK3 gene that could predict which GS7 prostate cancer patients will have a more aggressive form of cancer.
Among the research institutions NCI funds across the United States, it currently designates 68 as Cancer Centers. Largely based in research universities, these facilities are home to many of the NCI-supported scientists who conduct a wide range of intense, laboratory research into cancer’s origins and development. The Cancer Centers Program also focuses on trans-disciplinary research, including population science and clinical research. The centers’ research results are often at the forefront of studies in the cancer field.